Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment

World Journal of Gastroenterology

Volumn 9, Issue 12, 2003, Pages 2695-2697

  Chan, Henry Lik Yuen ^a   Wong, May Ling ^a   Hui, Alex Yui ^a   Chim, Angel Mei Ling ^a   Tse, Ada Mei Ling ^a   Hung, Lawrence Cheung Tsui ^a   Chan, Francis Ka Leung ^a   Sung, Joseph Jao Yiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOTIDE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; REFERENCE VALUE; SEROCONVERSION; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME;

EID: 0348228049     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i12.2695     Document Type: Article

References (21)

1. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489-503
2. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotypes of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000; 81: 67-74
3. Chan HLY, Wong ML, Hui AY, Hung LCT, Chan FKL, Sung JJY. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol 2003; 41: 1277-1279
4. Sung JJY, Chan HLY, Wong ML, Tse CH, Yuen SCH, Tam JSL, Leung NWY. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients. J Viral Hepat 2002; 9: 229-223
5. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanada E, Suzuki K, Watanabe H, Huge S, Mizokami M. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34: 590-594
6. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcome in patients with chronic hepatitis B. Gastroenterology 2000; 118: 554-559
7. Chan HLY, Tsang SWC, Liew CT, Tse CH, Wong ML, Ching JYL, Leung NWY, Tam JSL, Sung JJY. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2002; 97: 406-412
8. Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002; 40: 1207-1209
9. Chu CJ, Hussain M, Lok ASF. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122: 1756-1762
10. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Kanda T, Fukai K, Kato M, Saisho H. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003; 37: 19-26
11. Akuta N, Suzuki F, Kobayashi M, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. J Hepatol 2003; 38: 315-321
12. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33: 998-1002
13. Wai CT, Chu CJ, Hussain M, Lok ASF. HBV genotype B is associated with better response in interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002; 36: 1425-1430
14. Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002; 36: 303-305
15. Westland C, Delaney W, Yang HL, Fry J, Brosgart C, Gibbs C, Miller M, Xiong S. Distribution and clinical response of HBV genotypes in phase III studies of adefovir dipivoxil. J Hepatol 2002; 36(Suppl): 105
16. Chan HLY, Leung NWY, Lau TCM, Wong ML, Sung JJY. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to anti-viral therapy. J Clin Microbiol 2000;38:3205-3208
17. Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF. Hepatitis B e antigen negative chronic hepatitis B in Hong Kong. Hepatology 2000; 31: 763-768
18. Lindh M, Anderson AS, Gusdal A. Genotypes, nt 1858 variants, and geographical origin of hepatitis B virus - Large-scaled analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-1293
19. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Barber J, Stephenson SL, Gray DF. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998; 339: 61-68
20. Lok ASF, Lai CL. Acute exacerbation in Chinese patients with chronic hepatitis B virus (HBV) infection. J Hepatol 1990; 10: 29-34
21. Yuen MF, Yuan HJ, Hui CK, Wong DK, Wong WM, Chan AO, Wong BC, Lai CL. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: Implications for antiviral therapy. Gut 2003; 52: 416-419